Gc Cell Corporation is a leading biotechnology company specializing in cell therapy and innovative medical solutions. Founded with a vision to transform healthcare through advanced stem cell technologies, Gc Cell focuses on the development and commercialization of groundbreaking therapies for various diseases. The company emphasizes research and development, aiming to harness the power of regenerative medicine to improve patient outcomes. With a team of dedicated scientists and professionals, Gc Cell is committed to fostering collaborations with academic institutions and industry partners to drive scientific advancements and bring novel treatments to market. Their portfolio includes promising candidates for neurological, hematological, and orthopedic applications, making significant strides in the field of regenerative healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#89 in Gyeonggi-do

#1,306 in South Korea

Gyeonggi-do, South Korea

Gc Cell Corporation

Forward Citations = 9

31 inventors:

Jong Seo Lee (4 out of 52 patents)

In Sik Hwang (4 out of 5 patents)

Bong Kook Ko (4 out of 10 patents)

4. Yu Kyeong Hwang (4 out of 6 patents)

5. Sungyoo Cho (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gc Cell Corporation. Retrieved from https://idiyas.com/company/gc-cell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]